Pharmaceutical Executive-12-01-2014

Pharmaceutical Executive
Column

December 19, 2014

How pharma companies can catch up to the requirements of the modern marketing model.

Pharmaceutical Executive

New ways for pharma to make sure its sales reps stay sharp amid a flood of new information and a more complex selling climate.

Pharmaceutical Executive
From the Editor

December 16, 2014

THE CALENDAR SAYS IT'S WRAP UP TIME, not just for gifts, but for some of the trends that shaped big Pharma-for good or bad-during the past year. A simple way to close the book on 2014 is to draw some insights from our three feature stories this month.

Pharmaceutical Executive
Column

December 15, 2014

Foreign governments are enacting anti-fraud legislation as part of broader efforts to crack down on corrupt practices involving pharmaceutical companies and healthcare professionals.

Features
Pharmaceutical Executive

December 15, 2014

Pharm Exec profiles Express Scripts' Chief Medical Officer, Dr. Steve Miller, whose rise to prominence as an articulate critic of drug industry prices symbolizes the growing clout of America's largest pharmacy benefit manager.

Two words define the future of commercialization project management: Faster and Better

Pharmaceutical Executive

Building an effective drug forecasting model today requires a revamped approach.

Pharmaceutical Executive
Features

December 10, 2014

partnerships, big pharma, data exchange, Business Development, M&A, Business Strategy, information exchange, dealmaking, Rebecca Ashkenazy, Alex Chang, Cyndi Green, Ted Miller, Christine de los Reyes, targeted medicine, R&D productivity

Pharmaceutical Executive
Column

December 01, 2014

Cleveland Clinic's Pick of Top 10 Advances for 2015.

Pharmaceutical Executive
Special Sponsored Section

December 01, 2014

Once considered a healthcare backwater, Algeria's expanding pharmaceuticals market is taking the African continent by storm.

Pharmaceutical Executive

The European Union is moving ahead, in its own slightly crabwise fashion, with its attempts to work out what healthcare budgets should be used for. The characteristic sideways gait results from the fact that this isn't strictly speaking an EU issue.